INCHEON, Korea, March 09, 2024 (GLOBE NEWSWIRE) -- Samsung Bioepis Co., Ltd. presented two new study results for its immunology portfolio – SB5, a biosimilar to Humira 1 (adalimumab), and SB17, a ...
This picture shows the graphical abstract: pathogen Group A Streptococcus camouflaging as red blood cells. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted ...
Building of Collaboration Between National Research Center of Pediatric Hematology, Oncology and Immunology, Professional Society and Medical Institutions in the Russian Federation: Unique Experience ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback